Central Bank & Trust’s Organon & Co OGN Stock Holding History

Central Bank & Trust’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-36	Closed	-$846	–	397
2023 Q1	$846	Buy	+36	New	+$967	﹤0.01%	391
2022 Q1	–	Sell	-163	Closed	-$5K	–	333
2021 Q4	$5K	Buy	163 +135	+482%	+$4.4K	﹤0.01%	302
2021 Q3	$1K	Sell	28 -1,003	-97%	-$32.1K	﹤0.01%	300
2021 Q2	$31K	Buy	+1,031	New	+$33.9K	0.01%	243

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Central Bank & Trust's OGN Position: Q2 2023 in Review

Central Bank & Trust sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 36 shares — an estimated $846 sold.

Central Bank & Trust first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $31K in Q2 2021. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

Central Bank & Trust reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
Central Bank & Trust sold 36 Organon & Co shares in Q2 2023, an estimated $846.
Central Bank & Trust first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
Central Bank & Trust's Organon & Co position peaked at $31K in Q2 2021.
726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Central Bank & Trust's 13F filing for Q2 2023, filed 13 Jul 2023.